Page last updated: 2024-10-29

ketamine and HTLV-I Infections

ketamine has been researched along with HTLV-I Infections in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

HTLV-I Infections: Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prommer, E1

Other Studies

1 other study available for ketamine and HTLV-I Infections

ArticleYear
Ketamine and HTLV-1 myelopathy: NMDA blockade and immunomodulation?
    Journal of pain and symptom management, 2006, Volume: 31, Issue:5

    Topics: Excitatory Amino Acid Antagonists; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunolo

2006